Form D · Biotechnology

EnGeneIC Ltd. (ABN: 59 091 336 499)

Lane Cove, New South Wales, C3 · CIK 0001522586

Offering snapshot reported Mar 2, 2015 · SEC filing

Reported sold
$4M
Offering amount: $10M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 12, 2014
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 2, 2015Initial$4,000,000No comparison1SEC filing
Mar 2, 2015Initial$7,000,000No comparison4SEC filing
Jul 27, 2011Amendment$1,022,691$22,736vs Jun 9, 20112SEC filing
Jun 9, 2011Initial$999,955No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-234972

Source: Form D, filed Mar 2, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Himanshu Brahmbhatt Director, Executive
Anjan Chatterji Executive
Graham Cole Executive
William Louis Delaat Director
Ergad Gold Director
Robert Graham Director
Jennifer Mac Diarmid Director, Executive
Roger Moore Director
David Seaton Executive
Mervyn John Turner Director
Stuart Wardman Browne Director
Richard Woods Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
Building 2 25 Sirius Road
Lane Cove, New South Wales, C3, 2066